Eupraxia Pharmaceuticals Inc.

Filed as EUPRAXIA PHARMACEUTICALS INC (COM), Equity As of 2026 Q2 among managers we track

In 2026 Q2 Nathan Fischel opened a position in Eupraxia Pharmaceuticals.

Who owns this now

Largest portfolio weights among holders, up to 0.3% (Nathan Fischel, Dafna Capital Management). Not free-float ownership.

Sorted by value, long equity only, as of 2026 Q2.

					History
Nathan Fischel, Dafna Capital Management	0.28%	New 0.28%	225,600	$1.5M	History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

13Fs that reported it each quarter. Click a bar for that quarter’s holders.